Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 1/2020

01-01-2020 | Metastasis | Original Article

Application of Perioperative Transfusion Trigger Score in Patients Undergoing Surgical Treatment of Malignant Tumor

Authors: Fan Zhang, Ze-Bing Zheng, Zhao-Qiong Zhu, De-Xing Liu, Jin Liu

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 1/2020

Login to get access

Abstract

The present study aimed to investigate the clinical effects of the brand new perioperative transfusion trigger score (POTTS) system in patients undergoing malignant tumor surgeries. 442 cases of patients diagnosed with malignant tumor were randomly selected (from January 2012 to December 2016) from Zunyi Medical University and were divided into 3 experimental groups. Patients in the POTTS group were transfused by the POTTS guideline perioperatively, while patients in the 7–10 g group were treated by the traditional transfusion guidelines existed (restrictive transfusion strategy), patients in the 10 g group should be transfused to keep the Hb level no less than 10 g/dL (liberal transfusion strategy). Baseline information, operation time, bleeding volume, transfusion amount, incision healing time, postoperative complications, metastasis and recurrence were observed and recorded. Postoperative short-term mortality was comparable of the 3 groups, 3 cases of death all occurred in 10 g group, there was no significant difference in the incidence of postoperative complications, including infectious complications and coagulation related complications. Follow-up to date, there were 25 cases, 29 cases and 29 cases of tumor recurrence and metastasis in the three groups, but no statistical difference observed. The present findings show that the POTTS transfusion system is more advantageous with regard to save blood and relieve economic burdens of patients, and does not affect the long-term recurrence and metastasis rate of malignant tumor.
Literature
1.
go back to reference McGrath C (2016) Blood transfusion strategies for hemostatic resuscitation in massive trauma. Nurs Clin North Am 51(1):83–93CrossRef McGrath C (2016) Blood transfusion strategies for hemostatic resuscitation in massive trauma. Nurs Clin North Am 51(1):83–93CrossRef
2.
go back to reference Deveau SR (2016) Blood products and their use in traumatic major haemorrhage. Emerg Nurse 23(9):31–37CrossRef Deveau SR (2016) Blood products and their use in traumatic major haemorrhage. Emerg Nurse 23(9):31–37CrossRef
3.
go back to reference Carson JL (2015) The shifting paradigm for transfusion of red blood cells. Clin Adv Hematol Oncol 13(3):152–154PubMed Carson JL (2015) The shifting paradigm for transfusion of red blood cells. Clin Adv Hematol Oncol 13(3):152–154PubMed
4.
go back to reference Klein HG, Flegel WA, Natanson C (2015) Red blood cell transfusion: precision vs imprecision medicine. JAMA 314(15):1557–1558CrossRef Klein HG, Flegel WA, Natanson C (2015) Red blood cell transfusion: precision vs imprecision medicine. JAMA 314(15):1557–1558CrossRef
5.
go back to reference Goodnough LT, Shah N (2015) Is there a "magic" hemoglobin number? Clinical decision support promoting restrictive blood transfusion practices. Am J Hematol 90(10):927–933CrossRef Goodnough LT, Shah N (2015) Is there a "magic" hemoglobin number? Clinical decision support promoting restrictive blood transfusion practices. Am J Hematol 90(10):927–933CrossRef
6.
go back to reference American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies (2006) Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists task force on perioperative blood transfusion and adjuvant therapies. Anesthesiology 105:198–208CrossRef American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies (2006) Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists task force on perioperative blood transfusion and adjuvant therapies. Anesthesiology 105:198–208CrossRef
7.
go back to reference Murphy MF, Wallington TB, Kelsey P et al (2001) Guidelines for the clinical use of red cell transfusions. Br J Haematol 113:24–31CrossRef Murphy MF, Wallington TB, Kelsey P et al (2001) Guidelines for the clinical use of red cell transfusions. Br J Haematol 113:24–31CrossRef
8.
go back to reference Hebert PC, Wells G, Blajchman MA et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417CrossRef Hebert PC, Wells G, Blajchman MA et al (1999) A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340:409–417CrossRef
9.
go back to reference Lacroix J, Hebert PC, Hutchison JS et al (2007) Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 356:1609–1619CrossRef Lacroix J, Hebert PC, Hutchison JS et al (2007) Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 356:1609–1619CrossRef
10.
go back to reference Hajjar LA, Vincent JL, Galas FR et al (2010) Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 304:1559–1567CrossRef Hajjar LA, Vincent JL, Galas FR et al (2010) Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 304:1559–1567CrossRef
11.
go back to reference Yu X, Chen W, Liu Z et al (2016) Safety and current status of blood transfusion in China: an update. Lancent Haematol 3(2):e60–e62CrossRef Yu X, Chen W, Liu Z et al (2016) Safety and current status of blood transfusion in China: an update. Lancent Haematol 3(2):e60–e62CrossRef
12.
go back to reference Carson JL, Carless PA, Hebert PC (2013) Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA 309(1):83–84CrossRef Carson JL, Carless PA, Hebert PC (2013) Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion. JAMA 309(1):83–84CrossRef
13.
go back to reference Chang TM (2015) Red blood cell replacement, ornanobiotherapeutics with enhanced red blood cell functions? Artif Cells Nanomed Biotechnol 43(3):145–147CrossRef Chang TM (2015) Red blood cell replacement, ornanobiotherapeutics with enhanced red blood cell functions? Artif Cells Nanomed Biotechnol 43(3):145–147CrossRef
14.
go back to reference Keyhanian Sh, Ebrahimifard M, Zandi M (2014) Investigation on artificial blood or substitute blood replace the natural blood. Iran J Ped Hematol Oncol 4(2):72–77PubMedPubMedCentral Keyhanian Sh, Ebrahimifard M, Zandi M (2014) Investigation on artificial blood or substitute blood replace the natural blood. Iran J Ped Hematol Oncol 4(2):72–77PubMedPubMedCentral
15.
go back to reference Kumar R, Sedky MJ, Varghese SJ et al (2016) Transfusion Related Acute Lung Injury (TRALI): a single institution experience of 15 years. Indian J Hematol Blood Transfus 32(3):320–327CrossRef Kumar R, Sedky MJ, Varghese SJ et al (2016) Transfusion Related Acute Lung Injury (TRALI): a single institution experience of 15 years. Indian J Hematol Blood Transfus 32(3):320–327CrossRef
16.
go back to reference Takei T, Amin NA, Schmid G et al (2009) Progress in global blood safety for HIV. J Acquir Immune Defic Syndr 52:127–131CrossRef Takei T, Amin NA, Schmid G et al (2009) Progress in global blood safety for HIV. J Acquir Immune Defic Syndr 52:127–131CrossRef
17.
go back to reference Berra L, Pinciroli R, Stowell CP et al (2014) Autologous transfusion of stored red blood cells increases pulmonary artery pressure. Am J Respir Crit Care Med 190(7):800–807CrossRef Berra L, Pinciroli R, Stowell CP et al (2014) Autologous transfusion of stored red blood cells increases pulmonary artery pressure. Am J Respir Crit Care Med 190(7):800–807CrossRef
18.
go back to reference Rerambiah LK, Rerambiah LE, Bengone C et al (2014) The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. Blood Transfus 12(3):330–333PubMedPubMedCentral Rerambiah LK, Rerambiah LE, Bengone C et al (2014) The risk of transfusion-transmitted viral infections at the Gabonese National Blood Transfusion Centre. Blood Transfus 12(3):330–333PubMedPubMedCentral
19.
go back to reference Chen A, Trivedi AN, Jiang L et al (2015) Hospital blood transfusion patterns during major noncardiac surgery and surgical mortality. Medicine (Baltimore) 94(32):e1342CrossRef Chen A, Trivedi AN, Jiang L et al (2015) Hospital blood transfusion patterns during major noncardiac surgery and surgical mortality. Medicine (Baltimore) 94(32):e1342CrossRef
20.
go back to reference Hovaguimian F, Myles PS (2016) Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: a context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology 125(1):46–61CrossRef Hovaguimian F, Myles PS (2016) Restrictive versus liberal transfusion strategy in the perioperative and acute care settings: a context-specific systematic review and meta-analysis of randomized controlled trials. Anesthesiology 125(1):46–61CrossRef
21.
go back to reference Prescott LS, Taylor JS, Lopez-Olivo MA et al (2016) How low should we go: a systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. Cancer Treat Rev 46:1–8CrossRef Prescott LS, Taylor JS, Lopez-Olivo MA et al (2016) How low should we go: a systematic review and meta-analysis of the impact of restrictive red blood cell transfusion strategies in oncology. Cancer Treat Rev 46:1–8CrossRef
22.
go back to reference Rohde JM, Dimcheff DE, Blumberg N et al (2014) Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 311:1317–1326CrossRef Rohde JM, Dimcheff DE, Blumberg N et al (2014) Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 311:1317–1326CrossRef
23.
24.
go back to reference Claas FH, Roelen DL, van Rood JJ et al (2001) Modulation of the alloimmune response by blood transfusions. Transfus Clin Biol 8(3):315–317CrossRef Claas FH, Roelen DL, van Rood JJ et al (2001) Modulation of the alloimmune response by blood transfusions. Transfus Clin Biol 8(3):315–317CrossRef
25.
go back to reference Blumberg N, Heal J, Chuang C et al (1988) Ferther evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg 207(4):410–415CrossRef Blumberg N, Heal J, Chuang C et al (1988) Ferther evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence. Ann Surg 207(4):410–415CrossRef
26.
go back to reference Vidal O, Metges JP, Elizalde I et al (2009) High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer. Br J Surg 96(12):1443–1451CrossRef Vidal O, Metges JP, Elizalde I et al (2009) High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer. Br J Surg 96(12):1443–1451CrossRef
27.
go back to reference Kim JK, Kim HS, Park J et al (2016) Perioperative blood transfusion as a significant predictor of biochemical recurrence and survival after radical prostatectomy in patients with prostate cancer. PLoS ONE 11(5):e0154918CrossRef Kim JK, Kim HS, Park J et al (2016) Perioperative blood transfusion as a significant predictor of biochemical recurrence and survival after radical prostatectomy in patients with prostate cancer. PLoS ONE 11(5):e0154918CrossRef
28.
go back to reference Hwang HK, Jung MJ, Lee SH et al (2016) Adverse oncologic effect s of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy. J Hepatobiliary Pancreat Sci 23(8):497–501CrossRef Hwang HK, Jung MJ, Lee SH et al (2016) Adverse oncologic effect s of intraoperative transfusion during pancreatectomy for left-sided pancreatic cancer: the need for strict transfusion policy. J Hepatobiliary Pancreat Sci 23(8):497–501CrossRef
29.
go back to reference Mortensen Frank V (2011) Cause-specific mortality associated with leukoreduced, buffy coat-depleted, or no blood transfusion after elective surgery for colorectal cancer a postrial 15-year follow-up study. Transfusion 51(2):259–263CrossRef Mortensen Frank V (2011) Cause-specific mortality associated with leukoreduced, buffy coat-depleted, or no blood transfusion after elective surgery for colorectal cancer a postrial 15-year follow-up study. Transfusion 51(2):259–263CrossRef
30.
go back to reference Francis DM (1991) Relationship between blood and tumour behaviour. Br J Surg 78(12):1420–1428CrossRef Francis DM (1991) Relationship between blood and tumour behaviour. Br J Surg 78(12):1420–1428CrossRef
31.
go back to reference Vamvakas E, Moore SB (1993) Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 33(9):754–765CrossRef Vamvakas E, Moore SB (1993) Perioperative blood transfusion and colorectal cancer recurrence: a qualitative statistical overview and meta-analysis. Transfusion 33(9):754–765CrossRef
32.
go back to reference McGehee RP, Dodson MK, Moore JL et al (1994) Effect of blood transfusion in patients with gynecologic malignancy. Int J Gynaecol Obstet 46(1):45–52CrossRef McGehee RP, Dodson MK, Moore JL et al (1994) Effect of blood transfusion in patients with gynecologic malignancy. Int J Gynaecol Obstet 46(1):45–52CrossRef
33.
go back to reference Greenawalt JA, Zernell D (2017) Autologous blood transfusion for postpartum hemorrhage. MCN Am J Matern Child Nurs 42(5):269–275CrossRef Greenawalt JA, Zernell D (2017) Autologous blood transfusion for postpartum hemorrhage. MCN Am J Matern Child Nurs 42(5):269–275CrossRef
34.
go back to reference Gonzalez DO, Cooper JN, Mantell E et al (2017) Perioperative blood transfusion and complications in children undergoing surgery for solid tumors. J Surg Res 216:129–137CrossRef Gonzalez DO, Cooper JN, Mantell E et al (2017) Perioperative blood transfusion and complications in children undergoing surgery for solid tumors. J Surg Res 216:129–137CrossRef
35.
go back to reference Eckel AM, Hess JR (2017) Transfusion practice in trauma resuscitation. South Med J 110(8):554–558CrossRef Eckel AM, Hess JR (2017) Transfusion practice in trauma resuscitation. South Med J 110(8):554–558CrossRef
36.
go back to reference Pérel Y, Runel C, Huguenin Y et al (2017) Transfusion and its specific problems in pediatrics and neonatology. Transfus Clin Biol 24(3):101–105CrossRef Pérel Y, Runel C, Huguenin Y et al (2017) Transfusion and its specific problems in pediatrics and neonatology. Transfus Clin Biol 24(3):101–105CrossRef
37.
go back to reference Nixon CP, Tavares MF, Sweeney JD (2017) How do we reduce plasma transfusion in Rhode Island? Transfusion 57(8):1863–1873CrossRef Nixon CP, Tavares MF, Sweeney JD (2017) How do we reduce plasma transfusion in Rhode Island? Transfusion 57(8):1863–1873CrossRef
Metadata
Title
Application of Perioperative Transfusion Trigger Score in Patients Undergoing Surgical Treatment of Malignant Tumor
Authors
Fan Zhang
Ze-Bing Zheng
Zhao-Qiong Zhu
De-Xing Liu
Jin Liu
Publication date
01-01-2020
Publisher
Springer India
Keyword
Metastasis
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 1/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01180-z

Other articles of this Issue 1/2020

Indian Journal of Hematology and Blood Transfusion 1/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine